Firefly Neuroscience (AIFF) Accumulated Expenses (2010 - 2026)

Firefly Neuroscience's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $453000.0 for Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 60.81% year-over-year to $453000.0 in Q1 2026; TTM through Mar 2026 was $453000.0, a 60.81% decrease from a year earlier, with the FY2025 full-year figure at $766000.0, down 52.89% from the prior year.
• Accumulated Expenses fell to $453000.0 in Q1 2026 per AIFF's latest filing, from $766000.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.9 million in Q4 2023 and bottomed at $1195.0 in Q4 2022.
• The 5-year median for Accumulated Expenses is $604079.0 (2023), against an average of $707864.6.
• Across the five-year window, Accumulated Expenses tumbled 99.77% in 2022 and surged 159063.18% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $1195.0 in 2022, then jumped by 159063.18% to $1.9 million in 2023, then declined by 14.51% to $1.6 million in 2024, then slumped by 52.89% to $766000.0 in 2025, then sank by 40.86% to $453000.0 in 2026.
• Per Business Quant, the three latest AIFF Accumulated Expenses figures stand at $453000.0 (Q1 2026), $766000.0 (Q4 2025), and $658000.0 (Q3 2025).